Ptc Therapeutics (PTCT) Acquisitions (2017 - 2018)
Ptc Therapeutics' (PTCT) quarterly Acquisitions came in at $48.9 million in Q3 2018, up 163.97% year-on-year from $18.5 million in Q3 2017, and up 163.97% quarter-over-quarter from -$76.4 million in Q3 2017.
Ptc Therapeutics (PTCT) Acquisitions (2017 - 2018) Analysis & Trends
Ptc Therapeutics' Acquisitions history runs 2 years deep, the most recent figure standing at $48.9 million for Q3 2018.
- On a quarterly basis, Acquisitions rose 163.97% year-over-year to $48.9 million in Q3 2018; TTM through Dec 2019 was $48.9 million, a 277.58% increase from a year earlier, with the FY2018 full-year figure at $48.9 million, changed N/A from the prior year.
- Acquisitions climbed to $48.9 million in Q3 2018 per PTCT's latest filing, from -$76.4 million in the prior quarter.
- Across five years, Acquisitions topped out at $48.9 million in Q3 2018 and bottomed at -$76.4 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 48.89 Mn |
| Sep 30, 2017 | -76.42 Mn |